D.E. Shaw & Co
RGLS

D.E. Shaw & Co’s Regulus Therapeutics RGLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-27,319
Closed -$28K 2634
2017
Q4
$28K Sell
27,319
-2,409
-8% -$2.47K ﹤0.01% 2489
2017
Q3
$37K Buy
+29,728
New +$37K ﹤0.01% 2445
2017
Q1
Sell
-61,881
Closed -$139K 2575
2016
Q4
$139K Buy
61,881
+5,007
+9% +$11.2K ﹤0.01% 2385
2016
Q3
$187K Buy
+56,874
New +$187K ﹤0.01% 2343
2016
Q2
Sell
-68,682
Closed -$476K 2649
2016
Q1
$476K Sell
68,682
-38,585
-36% -$267K ﹤0.01% 2082
2015
Q4
$935K Buy
107,267
+55,433
+107% +$483K ﹤0.01% 1792
2015
Q3
$339K Buy
+51,834
New +$339K ﹤0.01% 2192
2015
Q2
Sell
-12,508
Closed -$212K 2710
2015
Q1
$212K Buy
+12,508
New +$212K ﹤0.01% 2359
2013
Q4
Sell
-25,411
Closed -$240K 2600
2013
Q3
$240K Buy
+25,411
New +$240K ﹤0.01% 2160